Fetal diagnosis and therapy · 2025
The Impact of Maternal Body Mass Index on Fetoscopic Laser Surgery for Twin-Twin Transfusion Syndrome.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Van der Veeken Lennart, Ziarko Isabelle, Kunpalin Yada, Abbasi Nimrah, Keunen Johannes, Flores-Mendoza Homero, Van Mieghem Tim, Ryan Greg
Аннотация
INTRODUCTION: Both a low and an increased body mass index (BMI) are risk factors for surgical complications. It is less clear whether they also affect the outcomes of fetoscopic procedures. In this manuscript, we aimed to assess the effect of maternal BMI on operative and pregnancy outcomes following fetoscopic laser ablation of placental anastomoses for twin-twin transfusion syndrome (TTTS).
METHODS: We retrospectively reviewed all patients with twin pregnancies complicated by TTTS treated with fetoscopic laser surgery at the Ontario Fetal Centre, Toronto, over a 24-year period. Demographic and procedural data as well as pregnancy and delivery outcomes were prospectively collected as part of our quality control program. Patients were divided into 6 groups for BMI at the time of surgery: BMI <20, 20-24.9, 25-29.9, 30-34.9, 35-39.9, and ≥40 kg/m2. Collected variables included demographics, operative characteristics, operative complications, obstetric complications, twin anemia-polycythemia sequence, TTTS recurrence, intrauterine (fetal) death, gestational age at delivery, and survival. Outcomes of all groups were compared to the "normal weight" reference cohort (BMI: 20-24.9 kg/m2).
RESULTS: Of 1,012 patients in our database, 859 were twin pregnancies treated with laser for TTTS. Pregnancy outcomes were available for 515. Of all patients, 47% were categorized as normal weight, 3% were underweight, 25% were obese, and 5% had a BMI of >40 kg/m2. Patients with a higher BMI had higher parity (p = 0.0001), longer cervical length (p = 0.008), and a significantly higher TTTS stage (p = 0.0003) at the time of surgery. There were no significant differences between groups in terms of surgical or anesthetic characteristics or perinatal complications.
CONCLUSION: BMI does not significantly affect operative or perinatal outcomes in patients undergoing fetoscopic laser ablation for severe TTTS, despite being at a higher stage at diagnosis.
METHODS: We retrospectively reviewed all patients with twin pregnancies complicated by TTTS treated with fetoscopic laser surgery at the Ontario Fetal Centre, Toronto, over a 24-year period. Demographic and procedural data as well as pregnancy and delivery outcomes were prospectively collected as part of our quality control program. Patients were divided into 6 groups for BMI at the time of surgery: BMI <20, 20-24.9, 25-29.9, 30-34.9, 35-39.9, and ≥40 kg/m2. Collected variables included demographics, operative characteristics, operative complications, obstetric complications, twin anemia-polycythemia sequence, TTTS recurrence, intrauterine (fetal) death, gestational age at delivery, and survival. Outcomes of all groups were compared to the "normal weight" reference cohort (BMI: 20-24.9 kg/m2).
RESULTS: Of 1,012 patients in our database, 859 were twin pregnancies treated with laser for TTTS. Pregnancy outcomes were available for 515. Of all patients, 47% were categorized as normal weight, 3% were underweight, 25% were obese, and 5% had a BMI of >40 kg/m2. Patients with a higher BMI had higher parity (p = 0.0001), longer cervical length (p = 0.008), and a significantly higher TTTS stage (p = 0.0003) at the time of surgery. There were no significant differences between groups in terms of surgical or anesthetic characteristics or perinatal complications.
CONCLUSION: BMI does not significantly affect operative or perinatal outcomes in patients undergoing fetoscopic laser ablation for severe TTTS, despite being at a higher stage at diagnosis.